Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us?

Idiopathic pulmonary fibrosis (IPF) is characterized by progressive parenchymal scarring, leading to dyspnoea, respiratory failure and premature death. Although IPF is confined to the lungs, the importance of IPF comorbidities such as pulmonary hypertension and ischaemic heart disease, lung cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Alfaro, Tiago M., Robalo Cordeiro, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074506/
https://www.ncbi.nlm.nih.gov/pubmed/32167024
http://dx.doi.org/10.1177/1753466620910092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074506/
https://www.ncbi.nlm.nih.gov/pubmed/32167024
http://dx.doi.org/10.1177/1753466620910092

Ejemplares similares